Join us at Health Research Day — June 6th at Canton Waterfront Park, Baltimore!   Learn More →
← Back to all trials
Completed NCT07846475

ALVEOLAR RIDGE SPLIT FOR FULL-ARCH MAXILLA

Conditions: Completely Edentulous Maxilla, Horizontal Alveolar Ridge Deficiency

Sex: All
Healthy volunteers: No
Enrollment: 47
Sponsor: Karadeniz Technical University

Summary

This retrospective study evaluated the use of the alveolar ridge split (ARS) technique in patients with a completely edentulous upper jaw who received implant-supported fixed prostheses. The ARS technique is used when the jawbone is too narrow to allow conventional implant placement. In this study, patients with insufficient maxillary ridge width underwent one-stage ARS with simultaneous implant placement, while patients with adequate ridge width received conventional implant placement without ridge splitting. The study compared the two treatment approaches in terms of implant survival, marginal bone loss around the implants, and implant success, including biological and prosthetic complications. A total of 47 patients with 332 dental implants were evaluated. The overall implant survival rate was 99.2%, and no significant difference was observed between the ARS and conventional implant groups. Marginal bone loss and implant success rates were also similar between the groups. The findings suggest that the alveolar ridge split technique may be a suitable option for implant-supported full-arch rehabilitation in carefully selected patients with a completely edentulous maxilla and insufficient alveolar ridge width.

Eligibility Criteria

Inclusion Criteria: * Completely edentulous maxilla requiring implant-supported fixed prosthetic rehabilitation. * Horizontal augmentation of the completely edentulous maxilla using the alveolar ridge split (ARS) technique in patients with insufficient ridge width (\

Interested in this study? View the official listing for contact and enrollment details.

View on ClinicalTrials.gov

Source: ClinicalTrials.gov (NCT07846475). StuddyBuddy aggregates publicly available trial information.